29.04.2024 08:06:38 - dpa-AFX: *ASTRAZENECA SAYS TRUQAP + FASLODEX RECOMMENDED FOR APPROVAL IN EU FOR PATIENTS WITH ADVANCED ER-POSITIVE BREAST CANCER

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
ASTRAZENECA PLC DL-,25 886455 Xetra 141,950 15.05.24 17:35:46 -0,800 -0,56% 0,000 0,000 142,850 142,750

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH